Novanta Inc
Novanta Inc. is a U.S.-based industrial technology company that supplies proprietary components and subsystems to original equipment manufacturers in medical and advanced industrial markets. Its portfolio includes motion control, laser beam delivery, machine vision, video processing, sensing, identification, and medical device technologies sold globally through direct sales and distribution channels.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueMedical-grade technologies and subsystems used in surgical, diagnostic, and life science equipment.
Precision technologies and components used in automation, manufacturing, and industrial OEM systems.
Customers
Novanta sells primarily to OEMs that integrate its technologies into medical devices and industrial equipment. Customers value application expertise, product performance, reliability, customization, and long design-in lifecycles, which can make supplier changes difficult once a product is adopted. The company also serves distributors and resellers in some channels, but direct technical selling remains central to the model.
Buy medical-grade subsystems and devices for surgical, diagnostic, and life science platforms; they need regulatory-ready, high-reliability components.
Buy precision technologies for automation, robotics, manufacturing, and inspection systems where performance and integration matter.
Indirect end demand for equipment used in hospitals, labs, and healthcare networks.
Purchase selected products to extend local market reach and support smaller accounts.
Strategy
Novanta’s strategy centers on proprietary technology solutions for long-life OEM platforms in medical and advanced industrial niches. The company emphasizes improving its mix toward medical end markets, expanding application expertise, and using acquisitions and product development to deepen its technology stack and customer relationships.
Medical programs tend to have long design cycles and sticky customer relationships.
Broader technology coverage improves cross-selling and customer retention.
Application support and service proximity are key differentiators in design-in markets.
Geography
Novanta sells products globally and maintains service and application centers in the United States, Europe, and Asia. The business has meaningful international exposure, with roughly 47% of revenue coming from customers outside the U.S., which makes foreign exchange, shipping, and cross-border supply chain execution important to operations.
Risks
Novanta faces demand cyclicality tied to medical capital spending, industrial production cycles, and OEM product launch timing. Its global footprint also exposes it to foreign exchange volatility, tariffs, supply chain disruption, cybersecurity incidents, and customer concentration, while goodwill and intangible assets require ongoing impairment judgment.
- Customer concentrationImpact: HighLikelihood: Medium
A small number of OEMs can represent a meaningful share of revenue, increasing dependence on their launch and purchasing decisions.
Exposure: Two OEM customers represented approximately 12% and 11% of 2025 revenue.
- Cyclical end-market demandImpact: HighLikelihood: Medium
Medical and advanced industrial sales depend on customer capital budgets, procedure volumes, and manufacturing investment cycles.
Exposure: Medical and advanced industrial end markets
- Cybersecurity and IT disruptionImpact: HighLikelihood: Medium
Operational systems connect with customers and suppliers, so outages or breaches can interrupt revenue and create liability.
Exposure: Customer and supplier systems
- Trade policy and inflationImpact: MediumLikelihood: High
Tariffs, retaliatory measures, and inflation can increase input costs and pressure pricing.
Exposure: Global manufacturing and sourcing
- Foreign exchange and international operationsImpact: MediumLikelihood: Medium
A large share of revenue is generated outside the U.S., creating translation and transaction exposure.
Exposure: Approximately 47% of revenue from outside the U.S.
Accounting
Judgemental itemsMost product revenue is recognized when control transfers on shipment, which can shift revenue between periods.
Impact: Affects quarterly comparability and cutoff judgments
Separately priced maintenance and warranty services are recognized over time.
Impact: Creates deferred revenue and timing differences
Acquisition-related goodwill and intangibles depend on future cash flow assumptions.
Impact: Can create non-cash charges if performance weakens
Precision components and OEM programs can create obsolescence and reserve risk.
Impact: May affect gross margin and working capital
The company operates across multiple jurisdictions and must estimate current and deferred taxes.
Impact: Can cause volatility in effective tax rate
Similar listed companies
Publicly listed companies with a comparable business focus.
Azenta, Inc.
AZTA · Special Industry Machinery, NEC
LivaNova PLC
LIVN · Electromedical & Electrotherapeutic Apparatus
LivaNova PLC is a medical technology company focused on therapies for cardiac and neurological conditions.
Envista Holdings Corp
NVST · Dental Equipment & Supplies
Envista Holdings Corp is a U.S.-based dental products company built around more than 30 brands, including Nobel Biocare, Ormco, DEXIS, and Kerr.
Novavax, Inc
NVAX · Biological Products, (No Diagnostic Substances)
Novavax is a U.S.-based biotechnology company focused on developing and commercializing protein-based vaccines and vaccine-related technologies.
Kadant Inc
KAI · Special Industry Machinery (No Metalworking Machinery)
Teleflex Incorporated
TFX · Surgical & Medical Instruments & Apparatus
Last updated: 24/09/2026